Long-term outcome of a dilated cardiomyopathy patient after mitral valve surgery combined with tissue-engineered myoblast sheets—report of a case
Shigeru Miyagawa(The University of Osaka), Yoshiki Sawa(Osaka Police Hospital), Köichi Toda(The University of Osaka), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Daisuke Yoshioka(The University of Osaka), Hiroki Hata(The University of Osaka), Keitaro Domae(The University of Osaka), Yasushi Yoshikawa(The University of Osaka), Ryouhei Matsuura(The University of Osaka)
Cited by 9
Related Papers
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Thoracic and cardiovascular surgeries in Japan during 2018
|General Thoracic and Cardiovascular Surgery|2020|123
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
|Circulation Journal|2021|115